Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Effects of TRRA1 in the Neurotrophic Keratopathy mouse model
Author Affiliations & Notes
  • Yuka Okada
    Ophthalmology, Wakayama Medical University, Kihoku Hospital, Japan
  • Makoto Tominaga
    Division of Cell Signaling,, National Institute for Physiological Sciences, Japan
  • Satomi Chiken
    Division of System Neurophysiology, National Institute for Physiological Sciences, Japan
  • Kenta Kobayashi
    Section of Viral Vector Development, National Institute for Physiological Sciences, Japan
  • Atsushi Nambu
    Division of System Neurophysiology, National Institute for Physiological Sciences, Japan
  • Takayoshi Sumioka
    Ophthalmology, Wakayama Medikal University, Japan
  • Shizuya Saika
    Ophthalmology, Wakayama Medikal University, Japan
  • Footnotes
    Commercial Relationships   Yuka Okada None; Makoto Tominaga None; Satomi Chiken None; Kenta Kobayashi None; Atsushi Nambu None; Takayoshi Sumioka None; Shizuya Saika None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 31. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yuka Okada, Makoto Tominaga, Satomi Chiken, Kenta Kobayashi, Atsushi Nambu, Takayoshi Sumioka, Shizuya Saika; Effects of TRRA1 in the Neurotrophic Keratopathy mouse model. Invest. Ophthalmol. Vis. Sci. 2024;65(7):31.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : A mouse model by coagulating the first branch of the trigeminal nerve delays corneal epithelial wound healing and simultaneously decreases expression of the perception-related cation channels TRPV4 and TRPA1 mRNA in the peripheral cornea (Lab invest, 2019). In this study, we investigated the effect of forced TRPA1 gene expression in this model.

Methods : Using previously reported methods, a model of neurotrophic keratopathy was created coagulating the first branch of the trigeminal nerve by 20-gauge bipolar needle. In this model, corneal epithelial wound healing is delayed, although corneal transparency is maintained.
(1) Three months after trigeminal coagulation, TRPA1 adeno-associated virus vector (TRPA1-AAV) (n=6) or control-AAV (n=6) was injected into the coagulated nerve. Four weeks after injection, epithelial defect (2mm diameter) were created in the cornea, and the rate of wound closure was compared by photographing the defects every 6 hours.
(2) The proliferation activity of the healing epithelium was determined by uisng BrdU-labeling in both group mice after 12 or 24hrs.

Results : (1) TRPA1-AAV group showed significantly smaller epithelial defects in the healing process after 6 and 12 hrs compared with control-AAV group. (2) BrdU-positive cells were increased after 12 and 24 hrs by TRA1-AAV group as compared with control AAV group in central and peripheral corneal epithelium.

Conclusions : Expression of TRPA1 in the injured trigeminal nerve restored the delayed corneal epithelial wound healing associated with neurotrophic keratopathy. TRPA1 channels are potential therapeutic targets for neurotrophic keratopathy.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×